The US FDA has recommended that paroxetine [`Paxil'] not be used in children and adolescents

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1393, 2003-01, pp. : 20-20

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

In Canada, GlaxoSmithKline has advised that the concomitant use of Paxil [paroxetine] and Orap [pimozide] is contraindicated

Reactions Weekly, Vol. 1, Iss. 1062, 2005-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Congenital malformation warning added to US Paxil/Paxil CR labels

Reactions Weekly, Vol. 1, Iss. 1071, 2005-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

In Canada, a Public Advisory warning against the concomitant use of Paxil [paroxetine] or Paxil controlled-release (CR) and Orap [pimozide]

Reactions Weekly, Vol. 1, Iss. 1063, 2005-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

The US FDA has approved acetadote [acetylcysteine] labelling updates

Reactions Weekly, Vol. 1, Iss. 1093, 2006-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

The US Congress has passed the FDA Amendments Act of 2007

Reactions Weekly, Vol. 1, Iss. 1171, 2007-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite